At Atara, our mission is to transform the lives of patients with serious diseases through pioneering science, teamwork and a commitment to excellence. We aim to offer hope to people whose lives have been impacted by cancer and autoimmune diseases.
EBV T cells naturally possess the following key characteristics:
Cells from donors are manufactured and stored in inventory with the goal of being readily available for patients with serious diseases
Next-generation technologies designed to:
Atara seeks to develop transformative therapies for patients with cancer, autoimmune, and viral diseases. CEO Pascal Touchon is presenting an overview of Atara's progress at this week's Cell & Gene Meeting on the Med by @alliancerm. #PTLD #MS #EBV #CART
This website uses cookies and similar technologies to optimise and improve the experience on our site. By continuing to use this website, you agree to the use of cookies and similar technologies as described in our Privacy Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.